Market Research Blog – Page 1523 – New Product Development

Floral Extract Market: Projected to Reach USD 3.8 Billion by 2029 | Says FMI

According to recently released data from Future Market Insights (FMI), the floral extract market is estimated to be valued at USD 2.6 billion in 2022. It is projected to reach USD 3.8 billion by 2029, with a compound annual growth rate (CAGR) of 4.3% from 2014 to 2021.

A new global trend has emerged recently: the rise of socially conscious consumers. This phenomenon has shifted consumers’ purchasing criteria.

With increased awareness, consumer demand for natural or organic products is rising, putting pressure on manufacturers to produce items with natural ingredients or fully organic products.

Ready to Make an Informed Decision? Contact Sales Now!

Floral Essential Oils Hold Significant Shares, Absolutes to Witness Rising Demand

While floral essential oils continue to influence the growth strategies, with revenue share of 65% in 2018, manufacturers are focusing on increasing the production of absolutes to capitalize on growing demand for premium fragrances and perfumes. On the one hand, floral concentrates will continue to represent relatively low share as compared to the two types of floral extracts, according to the report.

Apart from serving as a natural ingredient in cosmetic and personal care products, floral extracts possess multi-functional properties such as medicinal and colorant, thereby increasing its application potential in the industry. The study forecasts that the sales of natural floral extracts to increase ~5% y-o-y in 2019, while rapid adoption of organic variants is likely to result in increased market share.

Increased awareness about health & skincare beneficial products along with rising acceptance of organically sourced products will continue to fuel the growth of floral extract market, as suggested by FMI’s analysis.

Browse Full Report:

High Growth Opportunities Abound in East Asia

Regions such as Europe & North America are expected to hold prominent market shares in terms of value. However, the East Asia market for floral extract is expected to project lucrative growth over the forecast period of 2019-2029. Gains will remain propelled by the rapid growth of the cosmetic industry in the region, in the view of growing inclination towards personal grooming and increased disposable income available for purchasing high-end products.

According to the FMI’s research, a majority of key players in floral extract market are directing their investments in R&D on extraction techniques. While distillation and solvent extraction methods are widely adopted for various flowers, manufacturers are targeted towards supercritical fluid extraction method that not only reduces the energy consumption but also eliminates residual solvent in the resulting extracts.

Significantly high application potential of floral extracts is identified in fragrances, which accounted for ~42% in 2018. The rise of vegan perfumes in line with strong desire for cosmetics and fragrances to be cruelty-free will contribute to the overall sales of floral extract. Manufacturers are further exploring the capabilities of floral extracts as colorant and fragrance enhancer in skincare products as well as body care & toiletries.

Sensing an increase in direct sourcing of floral extracts to avoid intermediates in the supply chain, manufacturers are focusing on deepening their collaboration with cosmetic producers. In addition, leading players in the floral extract market are aiming to introduce their own product line of cosmetics and personal care.

Global Floral Extract Market by Category

By Extracts:

Concretes
Absolutes
Essential Oil

By Nature:

Organic
Natural

By Source:

Jasmine
Rose
Lavender
Tuberose
Mimosa
Marigold
Lotus
Ylang Ylang
Frangipani
Chmapaca
Others

By Method:

Solvent Extraction
Distillation
Expression (Cold Pressed)
Supercritical Fluid Extraction

By Application:

Skincare
- Creams, Lotion
- Facial Cleansers & Toner
- Serum
- Sunscreen
- Facepacks/Masks
- Anti-Ageing & Anti-Pollution Products
Haircare
- Shampoos & Shower Gel
- Conditioner & Serum
- Hair Rinses
- Hair Color & Dye
- Hair Oil & Tonics
Makeup
- Facial Products
- Eye Products
- Lip Products
- Nail Products
Body Care & Toiletries
- Soap
- Body Wash
- Massage & Bath Oil
Fragrances
- Perfumes
- Deodorants
- Colognes

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Seating and Positioning Belts Market Set to reach a size of USD 27.32 Billion by 2033

The global seating and positioning belts market is poised for substantial growth, with a projected worth of USD 14.42 Billion in revenue by 2023. According to market analysis, this sector is anticipated to expand at a robust CAGR of 6.6%, reaching an estimated market size of USD 27.32 Billion by 2033.

In today’s fast-paced society, safety stands as the paramount concern. Seating and positioning belts serve as critical components in safeguarding individuals against potential life-threatening situations. Tragically, each year, numerous fatalities occur due to the absence of proper seating or positioning belts.

Optimize Your Strategy with Actionable Insights: Access Checkout Comprehensive Reports

While awareness levels vary across regions, markets in the U.K. and U.S. boast higher rates of informed commuters compared to those in India or China. Additionally, seating and positioning belts are integral within the healthcare sector, particularly for individuals managing disabilities, as well as in various high-risk occupational settings.

The global landscape features numerous active seating and positioning belt markets. Although China and India represent significant markets, their growth is driven by both local demand and a substantial influx of importers seeking quality, budget-friendly products from these fragmented markets.

Seating and Positioning Belts Market: Key takeaways

Drivers:

Strong European Presence: Established European players dominate the market with expertise and influence across Europe.
China’s Industrial Growth: Demand for industrial safety belts in China is rising rapidly.
Safety Awareness Gap in China: China’s seating and positioning belt market relies on imports due to lower domestic safety awareness.
Cost-Effective Options: The increasing demand for affordable yet high-quality safety belts is driving market growth globally.
India’s Market Strength: Indian manufacturers cater to both domestic and international markets in Southeast Asia, Dubai, the US, and Latin America.

Restraints:

Uneven Demand: Public safety awareness and willingness to invest in safety gear varies significantly across regions.
Balancing Safety and Cost: Balancing affordability with essential safety features can be challenging for manufacturers.
Skilled Workforce: A skilled workforce is crucial for producing high-quality seating and positioning belts.

Instant Report Access – Empower Your Strategy with Key Insights

Key Market Players:

Some of the leading players in the seating and positioning belts market include:

Autoliv (Sweden)
ZF Friedrichshafen AG (Germany)
Denso Corporation (Japan)
Takata Corporation (Japan)
Magna International Inc. (Canada)
TRW Automotive Holdings Corp. (United States)
Daicel Corporation (Japan)
Toyoda Gosei Co., Ltd. (Japan)
Kyungshin Industry Co., Ltd. (South Korea)
Sabelt S.p.A. (Italy)

Market Segmentation:

By Vehicle Type:

Passenger Cars
Light Commercial Vehicles (LCVs)
Heavy Commercial Vehicles (HCVs)
Buses & Coaches
Two-Wheelers (Motorcycles & Scooters)

By Technology:

Passive Seat Belts (Traditional 2-point & 3-point belts)
Active Seat Belts (Pretensioners, load limiters, and airbag webbing)

By Distribution Channel:

OEM (Original Equipment Manufacturer)
Aftermarket

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Gamma Knife Market Set to Reach USD 702.5 Million by 2033 surge at a CAGR of 7.6% | FMI

The global gamma knife market is poised to achieve a significant valuation of USD 337.7 million by 2023, fueled by robust research and development activities. According to market projections, this growth trajectory is expected to create expansive opportunities, with a projected compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. By 2033, the market is anticipated to soar to approximately USD 702.5 million.

A key driver behind this growth is the increasing focus on healthcare initiatives worldwide. Both public and private sector investments aimed at enhancing healthcare infrastructure, particularly in emerging economies, are paving the way for gamma knife providers to extend their market footprint and accessibility.

Elevate Your Business Strategy with Exclusive Insights: Request Checkout Now

Gamma knife technology represents a non-invasive treatment option for various brain disorders, offering precise and targeted radiation therapy. As advancements in medical technology continue to evolve, the demand for gamma knife procedures is expected to rise, further bolstering market expansion.

“The projected growth of the gamma knife market underscores the importance of ongoing research and development efforts,” said FMI. “We anticipate continued innovation in this field to drive adoption rates globally, benefiting patients and healthcare providers alike.”

The promising outlook for the gamma knife market highlights its pivotal role in modern healthcare systems, offering patients minimally invasive treatment options with reduced recovery times compared to traditional surgery.

Key Takeaways from the Market Study:

Global gamma knife market was valued at USD 313.8 million by 2022-end.
From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
The market in India is expected to expand at a CAGR of 11.4% through 2033.
By disease, the brain metastases segment to account for a share of 69.2% in 2033.
From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
By 2033, the market value of gamma knife is expected to reach USD 702.5 million.

Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.

Gain Strategic Advantage – Get A Full Report

Competitive Landscape:

Prominent players in the gamma knife market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.

Recent Developments:

In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.

Segmentation Analysis of the Gamma Knife Market

By Disease Indication:

Brain Metastasis
Cancer
Arteriovenous Malformation
Trigeminal Neuralgia
Others

By Anatomy:

Head
Neck
Other Body Parts

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Radio Frequency Beauty Equipment Market share is projected to be USD 1,947.8 Million by 2033

The global radio frequency beauty equipment market is set to experience a profound transformation over the next decade, according to recent market research. Forecasts predict a remarkable surge from USD 377.7 million in 2023 to a staggering USD 1,947.8 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 17.8%. This anticipated growth underscores a period of dynamic expansion and abundant opportunities within the industry.

Future Market Insights (FMI), a leader in market research and consulting, stands ready to spearhead advancements in RF beauty technology. As the market gears up for substantial growth, FMI’s steadfast commitment to innovation and excellence in beauty and wellness technology positions it as a frontrunner poised to capitalize on this wave of market expansion.

Checkout Now to Access Industry Insights

Commenting on the market projections, a spokesperson for FMI stated, “We are thrilled about the immense potential within the RF beauty equipment market. Our dedication to pioneering solutions will enable us to meet the evolving needs of consumers and alike, driving forward progress and setting new benchmarks in the industry.”

RF technology in beauty equipment offers non-invasive, effective solutions for skin tightening, wrinkle reduction, and body contouring, catering to a growing consumer demand for non-surgical cosmetic procedures globally. FMI’s strategic focus on innovation ensures that it remains at the forefront of these advancements, delivering cutting-edge solutions that redefine beauty and wellness standards.

As FMI prepares to navigate this period of accelerated growth, the company remains committed to collaborating closely with industry partners and stakeholders to drive innovation and unlock new opportunities in the RF beauty equipment market.

Key Takeaways from the Radio Frequency Beauty Equipment Market Report:

The radio frequency beauty equipment market gained revenue of a total of USD 344.5 million in 2022.
The United States market revenue is not just higher in North America, but also globally. By acquiring a total of about 27.6% in 2023, the United States market enjoys a prominent global presence.
The United Kingdom market in Europe is predicted to thrive at a CAGR of 20.7% throughout the forecast period.
Asian countries like China and India are predicted to witness CAGRs of 26.4% and 24.3% through 2033.
The trolley mounted devices sub-segment acquires about 52% share of the global market by product.
By application, body contouring holds a prominent share of around 51% in 2023.

Key Developments in the Radio Frequency Beauty Equipment Market:

In February 2023, Professional Beauty Group announced that the key aesthetic brands from across the globe will be showcased at the Professional Beauty London from March 5 to 6. The brands showcased their latest technology and devices to bring a revolution in beauty businesses, and their clients and treatment menus.
In February 2023, Candela, a pioneer of the first and only long-pulse RF micro-needling device, and a prominent provider of energy-based solutions, reported the launch of a new FDA-permitted Profound Matrix™ system.
In March 2021, Tentech Inc. introduced ‘10THERMA’, which is a 5th-generation radio-frequency machine devised for skin tightening. The beauty device is distributed to aesthetic spas and salons, covering over 600 units in eight months after its launch.

Enhance Your Strategy – Get Full Report Access Instantly

Key Players in the Radio Frequency Beauty Equipment Market:

Cynosure, Inc.
Lumenis
Syneron Medical Ltd
Bausch Health Companies Inc.
Alma Lasers
Cymatics
IBRAMED
Guangzhou Beautylife Electronic Technology Co.
SharpLight Technologies Ltd
Venus Concepts
Airsculpt Technologies, Inc.

Key Market Segments in the Radio Frequency Beauty Equipment Market:

By Product:

Trolley Mounted Devices
Table Top Devices
Portable Devices

By Application:

Skin Treatment
- Skin Reconstruction
- Scar Removal
- Non-Surgical Skin Tightening
- Facial Repair
Body Countering
- Liposuction
- Cellulite Reduction
- Non-surgical Fat Reduction
- Collagen Stimulation and Generation
Hair Removal
Others

By Technology:

Monopolar RF
Bipolar RF
Multipolar RF
Fractional RF
Combination of IPL and RF

By End-use Sector:

Beauty Care Centers
Home Care Settings

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Sleep Apnea Diagnostic Systems Market is anticipated to reach USD 9.27 Billion by 2033

The global sleep apnea diagnostic systems market has achieved a historic milestone, reaching a valuation of USD 4.81 billion in 2023. Industry projections indicate robust growth ahead, with experts predicting a compound annual growth rate (CAGR) of 6.8% from 2023 to 2033. This trajectory positions the market to exceed USD 9.27 billion by 2033, underscoring its rapid evolution and expanding significance within healthcare.

At the forefront of this transformative industry landscape is Future Market Insights (FMI). Recognized for its unwavering commitment to innovation and excellence, FMI has played a pivotal role in advancing sleep apnea diagnosis through cutting-edge diagnostic systems. These systems are meticulously designed to meet the evolving needs of healthcare professionals and patients, setting new benchmarks in accuracy, efficiency, and patient care.

Get Market Intelligence: Checkout Now to Access

“FMI is dedicated to shaping the future of sleep apnea diagnosis,” said at Future Market Insights. “Our relentless pursuit of innovation has enabled us to develop state-of-the-art diagnostic solutions that empower healthcare providers worldwide to deliver superior patient outcomes.”

FMI’s contributions extend beyond technological innovation. The company’s comprehensive market insights and strategic guidance have empowered stakeholders to navigate the complexities of the sleep apnea diagnostic systems market effectively. By fostering collaboration and driving industry standards, FMI continues to drive positive change and elevate standards of care globally.

As the market continues to expand, FMI remains committed to pushing the boundaries of possibility in sleep apnea diagnosis. Through continued research, development, and strategic partnerships, FMI is poised to lead the industry into a future defined by innovation and improved patient outcomes.

Key Takeaways:

In 2022, the market for sleep apnea diagnostic systems in North America held a value share of 53.2%, with the United States contributing 48.0%.
Europe accounted for a value share of 19.3% in the sleep apnea diagnostic systems industry in 2022, with Germany representing 3.2%.
The actigraphy monitoring devices segment dominated the market in 2022, holding a significant value share of 39.68% based on product type.
The market value of sleep apnea diagnostic systems reached USD 4.52 billion in 2022, exhibiting a CAGR of 5.7% from 2018 to 2022.
Within the market, the sleep centers and clinics sub-segment was predicted to hold a 38.93% share in 2022 based on end-use.

How Intense Is the Competition in the sleep apnea diagnostic systems industry?

The competition in the sleep apnea diagnostic systems industry size is intense, driven by the growing demand for advanced diagnostic solutions.

Key market players are continuously engaged in research and development activities to introduce innovative products and gain a competitive edge.

The market is characterized by the presence of both established companies and emerging players, striving to expand their market share.

Competitive strategies such as mergers and acquisitions, partnerships, and product launches are commonly observed in the market.

The companies are focusing on enhancing their distribution networks and strengthening their presence in untapped markets to capitalize on the increasing opportunities in the sleep apnea diagnostic systems industry.

Elevate Your Business Game – Get the Full Report Instantly

Key Players:

Koninklijke Philips N.V.
Becton, Dickinson and Company
Braedon Medical Corporation
Advanced Brain Monitoring Inc.
SOMNOmedics GmbH
ResMed Inc.
BMC Medical Co. Ltd.
Natus Medical Incorporated
MGC Diagnostics Corporation
Cleveland Medical Devices Inc.
Others

Sleep Apnea Diagnostic Systems Industry by Category:

By Product:

Polysomnography (PSG) Devices
- Ambulatory PSG Monitoring Devices
- Clinical PSG Monitoring Devices
- Sleep Apnea Screening Device
Nasal Flow Sensors
Peripheral Capillary Oxygen Saturation (SPO2)
Actigraphy Monitoring Devices

By End-User Type:

Home Care Settings
Hospitals
Sleep Centers & Clinics

By Region:

North America
Latin America
Eastern Europe
Western Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Renal Biomarker Market Set to Surge to USD 3,031.8 Million by 2034 a moderate CAGR of 7%

The global renal biomarker market is on a robust growth trajectory, anticipated to surge from a valuation of USD 1,541.2 million in 2024 to an impressive USD 3,031.8 million by 2034. This growth, projected at a compound annual growth rate (CAGR) of 7%, underscores the increasing demand for advanced diagnostic solutions in the realm of kidney health.

The escalating prevalence of chronic kidney diseases (CKD) worldwide is a primary driver for the burgeoning demand for biomarker-based diagnostic tools. These biomarkers are crucial for the early detection and intervention of CKD, enabling better patient outcomes and management. Concurrently, the heightened awareness about the significance of kidney health, coupled with the rising incidence of diabetes and hypertension, is fueling market expansion.

Checkout Now to Access Strategic Intelligence

Innovative advancements in biomarker discovery technologies are further propelling market growth. Techniques such as omics approaches and high-throughput screening are accelerating the identification of novel biomarkers, thereby enhancing diagnostic accuracy and clinical utility. These technological strides are pivotal in addressing the diverse diagnostic needs and improving the reliability of biomarker assays.

However, the market faces challenges related to the variability in biomarker expression across different patient populations and disease stages. This variability hampers the standardization and reproducibility of biomarker assays, which in turn, limits their clinical utility. Addressing these challenges is essential for the sustained growth and adoption of biomarker-based diagnostics in clinical settings.

As the global healthcare landscape continues to evolve, the renal biomarker market is set to play a critical role in the early diagnosis and management of CKD. Stakeholders in the healthcare industry are encouraged to invest in research and development to overcome existing challenges and leverage emerging opportunities in this dynamic market.

Key Takeaways from the Market Study:

By biomarker type, the functional biomarker is accounted to hold a market share of 54.9% in 2024.
The United States is expected to register at a CAGR of 7.8% by 2034.
The United Kingdom registers significant growth, projected at a CAGR of 8.5% by 2034.
Based on diagnostic technique, the enzyme linked immunosorbent assay segment is accounted to hold a market share of 46.7% in 2024.

“The rising demand for biomarker-based diagnostic solutions to address the escalating CKD epidemic propels market growth, as healthcare providers prioritize preventive measures and proactive management of kidney health,” comments a Future Market Insights analyst.

Competitive Landscape:

Multinational corporations, biotechnology firms, and academic institutions characterize the competitive landscape of the renal biomarker market.

Lucrative key players dominate the market with their innovative biomarker assays and extensive research expertise, driving market competition and innovation.

Some of the key developments are:

In November 2022, Revelation Biosciences Inc. announced the results of a recent exploratory biomarker analysis, unveiling clinical development plans for REVTx-300 in treating chronic kidney disease (CKD) and acute kidney injury (AKI).
In 2023, Siemens Healthineers AG made a significant advancement in the renal biomarker market by introducing a novel biomarker panel to improve the diagnosis and management of renal diseases.

Enhance Your Business Strategy – Access the Full Report Instantly

Key Companies Profiled:

Abbott Laboratories
BioPorto Diagnostics AS
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Nexelis (Pacific Biomarkers)
BioMérieux
Sphingotec GmbH
Randox Laboratories Ltd
Siemens Healthineers AG
Beckman Coulter Inc. (Danaher Corporation)
Bio-Rad Laboratories Inc.

Key Segments:

By Biomarker:

Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-regulated Proteins
Neutrophil Gelatinase-Associated Lipocalin
Kidney Injury Molecule-1
Interleukin-18
Others

By Diagnostic Technique:

Enzyme Linked Immunosorbent Assay (ELISA)
Particle-Enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography-Mass Spectrometry (LS-MS)

By End User:

Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Teleradiology Services Market Set for Unprecedented Growth, Forecast to Reach USD 22,069.5 Million by 2033 a stunning CAGR of 12.20%

In a significant development for the healthcare sector, recent industry analysis forecasts that the global teleradiology services market is poised for unprecedented growth. The market, valued at USD 6,221.2 million in 2023, is expected to skyrocket to over USD 22,069.5 million by 2033. This projection indicates a robust compound annual growth rate (CAGR) of 12.20% over the next decade.

Teleradiology, the practice of transmitting radiological patient images from one location to another for consultation and diagnosis, is becoming increasingly vital in the medical field. This growth is fueled by the sector’s capability to significantly enhance healthcare accessibility and efficiency, particularly in remote and underserved areas. As the demand for remote diagnostic services increases globally, teleradiology is becoming a critical component in the evolving landscape of medical services.

Strengthen Your Strategy with Critical Business Insights: Checkout the Report

Key Takeaways: Teleradiology Service Market Poised for Strong Growth

The global teleradiology service market is expected to reach a value of over USD 22,069.5 million by 2033, reflecting a significant CAGR of 12.20%.
India: The market is anticipated to grow at a staggering 18.3% CAGR, driven by rising healthcare facilities and chronic disease burden.
Germany: A 4.4% CAGR is forecast, supported by a modern health information infrastructure and focus on preventive care.
Japan: The market is expected to rise at a 7.1% CAGR, fueled by government-backed telehealth policies and expansion into remote psychiatry.
Australia: A growth rate of 13.4% CAGR is projected, driven by a focus on healthcare research, digital health infrastructure, and government support for telehealth.
China: The market is anticipated to grow at a 15.9% CAGR, fueled by government investment in healthcare infrastructure and rapid technology adoption.

Recent Developments Observed by FMI:

LevelJump Healthcare Corp., a Canadian pioneer in B2B telehealth solutions, announced in September 2023 that its wholly owned subsidiary, Canadian Teleradiology Services (“CTS”), has acquired a new contract to provide teleradiology services. CTS is expanding its services outside Ontario, now offering remote radiological readings to Circle West Ultrasound Diagnostics and Warman Medical Imaging in Saskatchewan. During the day, the duty entails readings for Ultrasound patients.
In October 2022, Teleradiology Solutions (TRS) launc its new facility in the Andhra Med Tech Zone (AMTZ). AMTZ and TRS will utilize this hub to connect pan-India government hospitals, state-wide rural health facilities (including those financed by the National Health Mission), and public-private partnerships with hospitals where TRS would provide remote radiological services.

Discover Key Insights – Get A Full Report Immediately

Key Players in the Global Teleradiology Service Market:

Teleradiology Solutions
Argus Radiology
SRL Diagnostics
USARAD Holdings Inc.
Vital Radiology Services
Teleradiology Providers
Telemedicine Clinic
TeleDiagnosys Services Pvt. Ltd
Imaging Advantage
Foundation Radiology Group
Direct Radiology
Imaging On Call LLC

Teleradiology Service Market Segmentation:

By Process Type:

Certified Reporting Services Process
Preliminary Reporting

By Service Type:

Emergency Nighthawk
Day Time Coverage
Subspecialty Reading
- Cardiac Imaging
- Neuroradiology
- Nuclear Scans
- Musculoskeleton Studies
Second Opinion
Clinical Trials

By Modality:

X-Ray Scans
Computerized Tomograph (CT) Scans
MRI Scans
Ultrasound Scans
Nuclear Scans
Cardiac Echo
Mammography
Electromammography

By End-user:

Hospitals
Clinics
Ambulatory Surgical Centres
Radiology Centres

By Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Dermatology Devices Market Set for Exponential Growth, Projected to Surpass USD 9,803 Million by 2033 with a CAGR of 6.5%

The global dermatology devices market is experiencing a phenomenal surge, poised for exponential growth over the next decade. Recent market analysis has revealed that the industry, valued at USD 5,213.0 million in 2023, is anticipated to exceed the USD 9,803.0 million mark by 2033. This remarkable trajectory is underlined by a compelling Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.

This forecast signifies an escalating demand for cutting-edge dermatological solutions on a global scale. With a focus on pioneering technologies and evolving treatment methodologies, the industry is witnessing an unprecedented influx of investments, research, and development initiatives.

Elevate Your Business Strategy with Exclusive Insights: Request Checkout Now

The projected growth reflects the increasing prevalence of skin disorders, rising awareness about skin health, and the growing adoption of minimally invasive cosmetic procedures. Advances in laser technology, cryotherapy, and light therapy are revolutionizing the treatment landscape, making dermatology devices more effective and accessible than ever before.

Industry experts attribute this upward trend to several factors, including the aging population, the rise in disposable incomes, and a heightened emphasis on aesthetic appeal. Additionally, the expansion of teledermatology and the integration of AI-driven diagnostic tools are enhancing the precision and efficiency of dermatological treatments.

As the market continues to evolve, stakeholders are encouraged to capitalize on the burgeoning opportunities within the dermatology devices sector. Companies are urged to invest in innovative product development and strategic collaborations to maintain a competitive edge and meet the growing consumer demand.

Key Takeaways from the Dermatology Devices Industry:

The laser segment in the dermatology devices market commands a significant 46.1% market share in 2023.
The skin rejuvenation application segment captures a substantial 21.6% market share in 2023 in the global dermatology devices industry.
Specialty dermatology clinics are the preferred choice for dermatological procedures in the dermatology devices market, holding a significant 38.9% market share in 2023.
In the United States, the laser segment dominates the dermatology devices market with a remarkable 46.1% market share in 2023, fueled by a growing aging population and widespread adoption of advanced laser technologies.
Germany’s dermatology devices market, representing 2.9% of the global market share in 2023, is characterized by precision and quality, with German manufacturers renowned for their innovative laser and cryosurgery devices.
Japan’s dermatology devices market, accounting for 3.7% of the global market share in 2023, is propelled by advancements in aesthetic dermatology, catering to an increasingly skin-conscious population.
Australia captures a 3.7% market share in the global dermatology devices market in 2023, driven by rising skin health awareness and a preference for home-use devices among its skincare-conscious populace.
China’s dermatology devices market boasts a significant 7.2% market share in 2023, primarily due to the rapid expansion of the aesthetic industry and strategic collaborations between manufacturers.
India’s dermatology devices market secures a substantial 5.8% market share in 2023, powered by the surge in cosmetic dermatology procedures and the availability of affordable dermatology devices.
The United Kingdom’s dermatology devices market leads with a 7.4% market share in 2023, largely driven by the thriving aesthetic clinics industry and the popularity of minimally invasive dermatological procedures.

Instant Report Access – Empower Your Strategy with Key Insights

Key Players Striving to Obtain Greater Share in the Dermatology Devices Industry:

The competitive landscape of the dermatology devices industry is marked by a dynamic interplay of established market leaders, innovative startups, and evolving technological trends. Market giants like Lumenis Ltd., Cynosure (a division of Hologic, Inc.), and Alma Lasers hold sway with their extensive product portfolios and global reach. In contrast, nimble startups such as Cutera Inc., Sciton Inc., and Syneron Candela inject innovation into the market, often disrupting traditional treatment methods with novel technologies.

Continuous technological advancements remain a driving force in the industry, with companies heavily investing in research and development. Innovations such as AI integration, smart devices, and portable equipment are reshaping the dermatology devices landscape. Global expansion efforts target emerging markets like China and India, capitalizing on the rising disposable income and growing skincare awareness.

Strategic collaborations between dermatology device manufacturers and healthcare institutions, coupled with product diversification spanning laser therapy, cryosurgery, and microdermabrasion, underscore the multifaceted competitive dynamics. Mergers and acquisitions are common, reshaping the market landscape as companies seek to expand their portfolios. Balancing cost competitiveness without compromising quality remains a central challenge, as consumers increasingly seek value-driven solutions.

Recent Developments in the Dermatology Devices Market:

Cynosure released their new PicoSure Pro gadget, the newest improvement to the PicoSure platform.
Cutera debuted its new Excel V laser, which is intended to be more successful and less uncomfortable for patients.
On June 15, 2023, Hologic unveiled their new SculpSure Body gadget, a non-invasive body shaping technology that employs radiofrequency radiation.
On June 8, 2023, Lumenis introduced their new UltraPulse Encore laser, which is intended to be more adaptable and effective for a wider range of skin treatments.
Alma Lasers introduced their new Harmony XL Pro device, a modular platform that can be utilized for various cosmetic treatments such as laser hair removal, tattoo removal, and skin resurfacing.

Key Companies in the Market:

Alma Lasers GmbH
Cynosure, Inc.
Solta Medical, Inc.
Cutera, Inc.
Syneron Medical Ltd.
Canfield Scientific, Inc.
3Gen
Aesthetic Group
Ambicare Health
Image Derm, Inc.
Lumenis, Ltd.
Bausch Health Companies Inc
Bruker Corporation
Carl Zeiss
Genesis Biosystems, Inc.
Heine Optotechnik GmbH & Co. Kg
Michelson Diagnostics, Ltd.
Photomedex, Inc.

Key Market Segments Covered In Dermatology Devices Industry Research:

By Product Type:

Lasers
Fractional
Diode
InfraRed 1319 nm
Alexandrite laser
Nd: YAG 1064 nm
Pulsed
Potassium Titanyl Phosphate (KTP)
IPL devices
RF Devices
Microdermabrasion Devices
Others

By application:

Vascular Lesions
Telangiectasia
Hemangiomas
Port wine stains
Venous lakes
Scar Removal
Red or hypertrophic scars
Hyperpigmentation
Tattoo removal
Hair removal
Wrinkle Removal
Acne Treatment
Skin Rejuvenation
Pore Reduction
Others

By End User:

Hospitals
Specialty Dermatology Clinics
Private Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Ophthalmic Lasers Market Set to Surge, Reaching USD 1.3 Billion by 2030

The global ophthalmic lasers market is on a robust growth trajectory, projected to expand from USD 884.3 million in 2022 to USD 1.3 billion by 2030, achieving a Compound Annual Growth Rate (CAGR) of 5.4%. This substantial growth is attributed to the rising prevalence of eye diseases worldwide and the growing demand for ophthalmic laser devices.

Eye health continues to be a critical concern among consumers, with heightened awareness and increased spending on eye care playing pivotal roles in market expansion. The demand for ophthalmic laser machines is further driven by the consumer preference for minimally invasive laser treatments, coupled with the rapid development in the market for treating eye infections.

Stay Ahead with Cutting-Edge Business Insights: Get Our Request Checkout Now

“The market’s steady growth underscores the increasing need for advanced and effective eye care solutions,” said FMI. “Our focus remains on innovating and providing cutting-edge ophthalmic laser technology to meet the evolving needs of both healthcare providers and patients.”

Key factors contributing to the market’s growth include:

Rising Prevalence of Eye Diseases: The global increase in conditions such as glaucoma, cataracts, and diabetic retinopathy is driving the need for advanced laser treatments.
Consumer Awareness and Spending: Growing awareness about eye health and a willingness to invest in advanced treatments are propelling market demand.
Preference for Minimally Invasive Treatments: Consumers are increasingly opting for laser treatments due to their minimally invasive nature, which offers reduced recovery times and improved outcomes.

The future of the ophthalmic lasers market looks promising, with ongoing technological advancements and increased adoption of laser treatments expected to continue driving growth.

Key Takeaways: Ophthalmic Lasers Market Growth

The global ophthalmic lasers market is expected to reach USD 1.3 billion by 2030, driven by a moderate CAGR of 5.4%.
Increasing prevalence of eye diseases like cataracts, especially in the aging population, is boosting demand for ophthalmic lasers.
The US leads the market due to high incidence of eye conditions, advanced technology, and favorable government support for laser surgery.
Germany’s market is growing due to a preference for painless laser procedures and strong presence of leading manufacturers.
China’s market is expected to see significant growth due to its rapidly aging population, rising awareness of laser treatments, and flourishing medical tourism.
The report identifies key investment opportunities in the market, catering to hospitals and ophthalmology clinics.
The study analyzes factors driving growth in Asia Pacific and explores the interrelation between ophthalmic lasers and laser therapy devices. Additionally, it examines strategies adopted by leading manufacturers.

Full Report Instantly – Drive Your Strategy Forward

Key companies profiled:

Abbott Medical Optics, Inc., Alcon Inc. (Novartis AG), Bausch & Lomb Incorporated, LENSAR, LLC, NIDEK CO., LTD, iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, and SCHWIND eye-tech-solutions GmbH & Co. KG.

Ophthalmic Lasers Market by Category:

By Product:

Excimer Lasers
Femtosecond Laser

By Application:

Refractive Surgery
Cataract Surgery
Posterior Capsulotomy
Trabeculoplasty
Diagnostic

By End User:

Hospital
- 500 Bedded+
- 250-499 Bedded
- Less than 250
Ambulatory Surgical Centers
Ophthalmology Clinics

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
South Korea
China
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Positron Emission Tomography (PET) Scanners Market Set for Robust Growth, Projected to Reach USD 2.1 Billion by 2033 grow at a CAGR of 5.3%

The global positron emission tomography (PET) scanners market is on the brink of substantial growth, with market value expected to surge from USD 1.3 billion in 2023 to USD 2.1 billion by 2033. This remarkable expansion underscores a Compound Annual Growth Rate (CAGR) of 5.3% over the next decade.

Several key factors are driving this impressive growth trajectory. Notably, groundbreaking advancements in medical imaging technology and an increasing recognition of the pivotal role that PET scanners play in early disease detection and diagnosis are at the forefront. These technological developments are revolutionizing the healthcare landscape, setting new standards for precision and effectiveness in medical interventions.

Optimize Your Strategy with Actionable Insights: Access Checkout Comprehensive Reports

PET scanners have become indispensable tools in the medical field, providing detailed insights into the human body’s complex functions. Their ability to facilitate the early detection of various health conditions is crucial. Early diagnosis enabled by PET scanners allows for timely and targeted treatment strategies, significantly improving patient outcomes.

As the market continues to evolve, the enhanced capabilities of PET scanners are expected to further solidify their role in healthcare, ensuring more accurate and effective medical diagnoses and interventions.

Key Takeaways:

The process incorporates the visualization of biochemical changes in the body, including the strong metabolism of the heart muscle. These efficient scanners employ a type of nuclear medicine process in order to accurately measure the metabolic activity of the body tissues and cells. It is a combination of nuclear medicine and biochemical analysis. They are mostly used in patients with heart or brain conditions, and cancer.
The surging adoption of PET and X-ray transmission computed tomography (CT) scans is expected to propel growth in the market over the upcoming years. This innovative technology is predicted to reduce acquisition time, and provides precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity.
Furthermore, the combination of PET and CT helps in improving the staging of disease by defining prognostic and treatment monitoring capabilities of the functional and metabolic information given by conventional nuclear imaging techniques.
Most PET scanning products are used to perform fluorodeoxyglucose (FDG) as it has the capability to capture tissue glucose metabolism and increase its parameters. Although, fluorodeoxyglucose consists of some shortcomings such as low specificity. Additionally, several potential radiotracers are under investigation to address the unmet clinical needs of diagnosis of diseases.
In order to tackle such diseases, various manufacturers are launching new products that come with higher sensitivity concerning metabolic activity to achieve detailed scans. Players are also investing in mergers and acquisitions to improve their product portfolios.
The market is expected to comprise mandatory equipment registered in several countries, regulatory requirements for development, and reimbursement changes. The market is highly influenced by the advances in minimally invasive surgical procedures and the establishment of new patented products.
Over the recent years, the market observed a surge in the BPS values owed to the potential benefits of digital PET scanners over conventional analog scanners attributed to their improved image quality, thus promoting greater adoption. In addition to that, the market experienced change within the BPS values owing to the reduction in the number of elective surgeries as well as the emergence of telehealth during the advent of the COVID-19 pandemic.

Unlock Full Report Insights Now – Elevate Your Business Strategy

Competitive Landscape:

Key market players are concentrating on a novel and innovative approaches for the development of positron emissions tomography scanners driven by emerging cases of infectious diseases and the lack of advanced methods for efficient detection. An expansion of the production facility along with new product launches and approvals are projected to further strengthen the growth of the market.

More Insights into the Positron Emission Tomography (PET) Scanners Industry

The U.S. is anticipated to dominate the North American market as it accounted for around 94.4% of the total market share in 2020. Due to the rising prevalence of cancer in the country, an underpinning need for advanced PET scanners, thereby creating sales prospects in the market.

Some of the prominent players in the market are:

G.E. Healthcare
Toshiba Corporation
Koninklijke Philips N.V.
Siemens Healthineers
Hitachi Medical Corporation
Positron Corporation
Mediso Ltd.
Yangzhou Kindsway Biotech Co., Ltd

Positron Emission Tomography (PET) Scanners Industry by Category:

By Product Type:

Full-ring PET Scanner
Partial-ring PET Scanner

By Application:

Oncology
Cardiology
Neurology
Others

By Detector Type:

Bismuth Germanium Oxide
Lutetium Oxyorthosilicate
Gadolinium Oxyorthosilicate
Lutetium Fine Silicate
Lutetium Yttrium Orthosilicate

By End User:

Hospitals
Diagnostic Centers
PET Centers
Research Institute

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: